Human recombinant apyrase therapy protects against myocardial ischemia/reperfusion injury and preserves left ventricular systolic function in rats, as evaluated by 7T cardiovascular magnetic resonance imaging

Authors

Ziqian Xu, Sichuan University
Wei Chen, Kunming Medical College
Ruzhi Zhang, Sichuan University
Lei Wang, Sichuan University
Ridong Chen, APT Therapeutics Inc.
Jie Zheng, Washington University School of Medicine in St. Louis
Fabao Gao, Sichuan University

Journal

Korean Journal of Radiology

Publication Date

2020

Volume

21

Issue

6

First Page

647

Last Page

659

Document Type

Open Access Publication

DOI

10.3348/kjr.2019.0853

Rights and Permissions

Xu Z, Chen W, Zhang R, Wang L, Chen R, Zheng J, Gao F. Human Recombinant Apyrase Therapy Protects Against Myocardial Ischemia/Reperfusion Injury and Preserves Left Ventricular Systolic Function in Rats, as Evaluated by 7T Cardiovascular Magnetic Resonance Imaging. Korean J Radiol. 2020 Jun;21(6):647-659. https://doi.org/10.3348/kjr.2019.0853 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Xu, Ziqian; Chen, Wei; Zhang, Ruzhi; Wang, Lei; Chen, Ridong; Zheng, Jie; and Gao, Fabao, "Human recombinant apyrase therapy protects against myocardial ischemia/reperfusion injury and preserves left ventricular systolic function in rats, as evaluated by 7T cardiovascular magnetic resonance imaging." Korean Journal of Radiology. 21, 6. 647 - 659. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9403